Thiazole-containing compounds as therapeutic targets for cancer therapy

In the last few decades, considerable progress has been made in Anticancer agents development, and several new Anticancer agents of natural and synthetic origin have been produced. Among heterocyclic compounds, thiazole, a 5-membered unique heterocyclic motif containing sulphur and nitrogen atoms, serves as an essential core scaffold in several medicinally important compounds. Thiazole nucleus is a fundamental part of some clinically applied Anticancer drugs, such as dasatinib, dabrafenib, ixabepilone, patellamide A, and epothilone. Recently, thiazole-containing compounds have been successfully developed as possible inhibitors of several biological targets, including enzyme-linked receptor(s) located on the cell membrane, (i.e., polymerase inhibitors) and the cell cycle (i.e., microtubular inhibitors). Moreover, these compounds have been proven to exhibit high effectiveness, potent Anticancer activity, and less toxicity. This review presents current research on thiazoles and elucidates their biological importance in Anticancer drug discovery. The findings may aid researchers in the rational design of more potent and bio-target specific Anticancer drug molecules.

1,3-Thiazoles; Anticancer activity; Biological targets; Cyclic peptides; Heterocycles.